These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35322921)

  • 41. [Enantioseparation and determination of atenolol enantiomers in tables on a β-cyclodextrin-based chiral stationary phase by high performance liquid chromatography].
    Cheng B; Li L; Zhou R; Nie G; Zhang H
    Se Pu; 2014 Nov; 32(11):1219-24. PubMed ID: 25771541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liquid chromatographic retention behavior and enantiomeric separation of three chiral center beta-blocker drug (nadolol) using heptakis (6-azido-6-deoxy-2, 3-di-O-phenylcarbamolyted) beta-cyclodextrin bonded chiral stationary phase.
    Wang X; Ching CB
    Chirality; 2002 Nov; 14(10):798-805. PubMed ID: 12395397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of temperature on enantiomer separation of oxzepam and lorazepam by high-performance liquid chromatography on a beta-cyclodextrin derivatized bonded chiral stationary phase.
    He H; Liu Y; Sun C; Wang X; Pham-Huy C
    J Chromatogr Sci; 2004 Feb; 42(2):62-6. PubMed ID: 15023256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A fully derivatized 4-chlorophenylcarbamate-β-cyclodextrin bonded chiral stationary phase for enhanced enantioseparation in HPLC.
    Sun J; Ma S; Liu B; Yu J; Guo X
    Talanta; 2019 Nov; 204():817-825. PubMed ID: 31357369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enantioseparation of chiral pharmaceuticals by vancomycin-bonded stationary phase and analysis of chiral recognition mechanism.
    Li J; Liu R; Wang L; Liu X; Gao H
    Chirality; 2019 Mar; 31(3):236-247. PubMed ID: 30677171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new single-urea-bound 3,5-dimethylphenylcarbamoylated β-cyclodextrin chiral stationary phase and its enhanced separation performance in normal-phase liquid chromatography.
    Lin C; Fan J; Liu W; Chen X; Ruan L; Zhang W
    Electrophoresis; 2018 Jan; 39(2):348-355. PubMed ID: 29044568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPLC enantioseparation of potential beta-blockers of the aryloxyaminopropanol type. Study of the mechanism of enantioseparation, Part VIII.
    Hrobonová K; Lehotay J; Cizmáriková R
    Pharmazie; 2004 Nov; 59(11):828-32. PubMed ID: 15587580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chiral mobile phase additives in HPLC enantioseparations.
    Yu L; Wang S; Zeng S
    Methods Mol Biol; 2013; 970():221-31. PubMed ID: 23283780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retention mechanism study of imidazole derivatives on a beta-cyclodextrin-bonded stationary phase. Thermal analysis contributions.
    Morin N; Guillaume YC; Peyrin E; Rouland JC
    Anal Chem; 1998 Jul; 70(14):2819-26. PubMed ID: 9684543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Separation of chiral furan derivatives by liquid chromatography using cyclodextrin-based chiral stationary phases.
    Han X; Yao T; Liu Y; Larock RC; Armstrong DW
    J Chromatogr A; 2005 Jan; 1063(1-2):111-20. PubMed ID: 15700462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation of a β-Cyclodextrin-Based Open-Tubular Capillary Electrochromatography Column and Application for Enantioseparations of Ten Basic Drugs.
    Fang L; Yu J; Jiang Z; Guo X
    PLoS One; 2016; 11(1):e0146292. PubMed ID: 26771454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative HPLC enantioseparation on substituted phenylcarbamoylated cyclodextrin chiral stationary phases and mobile phase effects.
    Lin C; Fan J; Liu WN; Tan Y; Zhang WG
    J Pharm Biomed Anal; 2014 Sep; 98():221-7. PubMed ID: 24937808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic insights on chaotropic interactions of liophilic ions with basic pharmaceuticals in polar ionic mode liquid chromatography.
    Sanganyado E; Lu Z; Gan J
    J Chromatogr A; 2014 Nov; 1368():82-8. PubMed ID: 25311487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enantioseparation of isoxazolines with functionalized perphenylcarbamate cyclodextrin clicked chiral stationary phases in HPLC.
    Yang B; Zhou J; Wang Y; Tang J; Tang W
    Electrophoresis; 2017 Aug; 38(15):1939-1947. PubMed ID: 28176345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclodextrins as a chiral mobile phase additive in nano-liquid chromatography: comparison of reversed-phase silica monolithic and particulate capillary columns.
    Rocco A; Maruška A; Fanali S
    Anal Bioanal Chem; 2012 Mar; 402(9):2935-43. PubMed ID: 22349325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resolution of terfenadine enantiomers by beta-cyclodextrin chiral stationary phase high-performance liquid chromatography.
    Weems H; Zamani K
    Chirality; 1992; 4(4):268-72. PubMed ID: 1389964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on chiral selective inclusion and retention characteristics of cis-trans isomers and enantiomers of sertraline with HP-beta-CD as a mobile phase modifier].
    Chen D; Chen Y; Hu Y
    Se Pu; 2004 Nov; 22(6):595-600. PubMed ID: 15807109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel approach to the study of the chiral discrimination. Mechanism in a series of imidazole derivatives using HPLC.
    Guillaume YC; Robert JF; Guinchard C
    Ann Pharm Fr; 2001 Nov; 59(6):392-401. PubMed ID: 11924511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPLC enantioseparation on cyclodextrin-based chiral stationary phases.
    Wang Y; Ng SC
    Methods Mol Biol; 2013; 970():69-79. PubMed ID: 23283771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chiral separation of racemic 5-(p-hydroxyphenyl)-5-phenylhydantoin by RP-HPLC using eluents containing beta-cyclodextrin].
    Yao T; Zeng S; Ding H
    Se Pu; 1997 Jul; 15(4):316-8. PubMed ID: 15739464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.